Altis Biosystems Revenue and Competitors
Estimated Revenue & Valuation
- Altis Biosystems's estimated annual revenue is currently $2.6M per year.
- Altis Biosystems's estimated revenue per employee is $77,500
Employee Data
- Altis Biosystems has 34 Employees.
- Altis Biosystems grew their employee count by 3% last year.
Altis Biosystems's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Associate Director, R&D | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
4 | Senior Director Marketing and Product Management | Reveal Email/Phone |
5 | Business and Finance Manager | Reveal Email/Phone |
6 | Senior Scientist, Manager Commercial Team | Reveal Email/Phone |
7 | Sr. Director Business Development | Reveal Email/Phone |
8 | Scientific Specialist I | Reveal Email/Phone |
9 | President & COO | Reveal Email/Phone |
10 | Associate Scientist | Reveal Email/Phone |
Altis Biosystems Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11.2M | 72 | -13% | N/A | N/A |
#2 | $5099.8M | 32902 | -4% | N/A | N/A |
#3 | $1.7M | 11 | 0% | N/A | N/A |
#4 | $0.6M | 4 | -56% | N/A | N/A |
#5 | $0.9M | 11 | -39% | N/A | N/A |
#6 | $1.7M | 11 | 10% | N/A | N/A |
#7 | $0.6M | 4 | -33% | N/A | N/A |
#8 | $4.8M | 31 | -6% | N/A | N/A |
#9 | $6.4M | 41 | 3% | N/A | N/A |
#10 | $4.2M | 27 | -18% | N/A | N/A |
What Is Altis Biosystems?
Altis has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research. The product is called RepliGut. It will allow drugs to be tested on an in vitro platform that more closely mimics native human biology. Our goal is to enable pharmaceutical companies to identify effective compounds earlier, before clinical trials; to reduce animal testing; and to make the drug development process faster, cheaper, and safer. Currently, 88% of drugs fail during clinical trials. Part of the reason is that during preclinical studies, drugs are tested using tumor cells and animals. These cannot accurately indicate the way that pharmaceuticals will behave in the human body. The current market lacks a viable method for testing drugs, prior to human testing, and RepliGut will more accurately reflect drug behavior in humans.
keywords:N/A
N/A
Total Funding
34
Number of Employees
$2.6M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Durham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.9M | 34 | N/A | N/A |
#2 | $5.3M | 34 | -21% | N/A |
#3 | $3.9M | 34 | N/A | N/A |
#4 | $7.9M | 34 | -8% | N/A |
#5 | $7.3M | 34 | 6% | N/A |